Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harlan Sprague Dawley was a premier global provider of laboratory animals and preclinical research services to the pharmaceutical, biotechnology, and academic sectors. The company was most famous for its production of standardized research models, including the ubiquitous Sprague Dawley rat, which became a foundational tool in biomedical research. Beyond animal models, Harlan offered a comprehensive suite of products and services, including specialized animal diets under the Teklad brand, laboratory bedding, and contract research services for toxicology and pharmacology. In 2015, the company merged with Huntingdon Life Sciences to form Envigo, which was subsequently acquired by Inotiv in 2021.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harlan Sprague Dawley.